BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 29455549)

  • 1. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
    Breza J; Breza J
    Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
    Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
    Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 2A in an Iranian family: clinical and genetic studies.
    Ghazi AA; Bagheri M; Tabibi A; Sarvghadi F; Abdi H; Hedayati M; Pourafkari M; Tirgari F; Yu R
    Arch Iran Med; 2014 May; 17(5):378-82. PubMed ID: 24784869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma in MEN 2A syndrome. Study of 54 patients.
    Rodriguez JM; Balsalobre M; Ponce JL; Ríos A; Torregrosa NM; Tebar J; Parrilla P
    World J Surg; 2008 Nov; 32(11):2520-6. PubMed ID: 18795243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess.
    Kim J; Reutrakul S; Davis DB; Kaplan EL; Refetoff S
    Eur J Endocrinol; 2004 Dec; 151(6):771-7. PubMed ID: 15588245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.
    Nguyen L; Niccoli-Sire P; Caron P; Bastie D; Maes B; Chabrier G; Chabre O; Rohmer V; Lecomte P; Henry JF; Conte-Devolx B;
    Eur J Endocrinol; 2001 Jan; 144(1):37-44. PubMed ID: 11174835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).
    Oishi S; Sato T; Takiguchi-Shirahama S; Nakamura Y
    Endocr J; 1995 Aug; 42(4):527-36. PubMed ID: 8556060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.
    Bethanis S; Koutsodontis G; Palouka T; Avgoustis C; Yannoukakos D; Bei T; Papadopoulos S; Linos D; Tsagarakis S
    Hormones (Athens); 2007; 6(2):152-6. PubMed ID: 17704047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical patterns and RET proto-oncogene identification of pheochromocytoma in 13 multiple endocrine neoplasia type 2A pedigrees].
    Qi XP; Chen ZG; Jin HY; Li F; Cheng J; Ying RB; Zhao JQ; Guo DG; Luo SY; Chen GP; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2200-4. PubMed ID: 24169328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
    Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):134-137. PubMed ID: 29397600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type 2A syndrome (MEN2A) and usefulness of 68Ga-DOTATATE PET/CT in this syndrome.
    Tuzcu SA; Pekkolay Z
    Ann Ital Chir; 2019; 90():497-503. PubMed ID: 30837349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple endocrine neoplasia type 2A].
    Juodele L; Krasauskas V; Zindzius A; Juozaityte E; Pundzius J
    Medicina (Kaunas); 2006; 42(3):215-24. PubMed ID: 16607064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endocrine neoplasia type 2A: case report.
    Păun DL; Poiană C; Petriş R; Radian S; Miulescu RD; Constantinescu G; Orban C
    Chirurgia (Bucur); 2013; 108(6):900-3. PubMed ID: 24331334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by
    Rotania M; Chabrier G; Imperiale A
    Endocrine; 2019 Dec; 66(3):691-692. PubMed ID: 31478160
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature.
    Oishi S; Sasaki M; Sato T; Isogai M
    Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 2A. Study of a family.
    Correia MJ; Lopes LO; Bugalho MJ; Cristina L; Santos AI; Bordalo AD; Pinho B; da Silva HL; Gonçalves MD; Ribeiro C; Tuna JL
    Rev Port Cardiol; 2000 Jan; 19(1):11-31. PubMed ID: 10731788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and mutations of RET proto-oncogene in a pedigree affected with type 2A multiple endocrine neoplasia].
    Zhang Y; Zheng X; Cheng L; Ma S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):106-109. PubMed ID: 28186607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.
    De Graaf JS; Dullaart RP; Kok T; Piers DA; Zwierstra RP
    Eur J Surg; 2000 Apr; 166(4):289-92. PubMed ID: 10817323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.